The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cells

This publication has 21 references indexed in Scilit:

• Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line
  Published by Elsevier ,2004
• ANTISENSE THERAPEUTICS IN HAEMATOLOGICAL MALIGNANCIES
  British Journal of Haematology, 1994
• Studies of the proliferation and differentiation of immature myeloid cells in vitro. II. Acute myelogenous leukemia
  American Journal of Hematology, 1989
• Bifunctional oligonucleotide probes synthesized using a novel CPG support are able to detect single base pair mutations
  Nucleic Acids Research, 1989
• Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
  Cell, 1986
• The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene
  Science, 1986
• Structural organization of the bcr gene and its role in the Ph′ translocation
  Nature, 1985
• Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
  Cell, 1984
• DNA-Flow Cytometry of Blood and Bone Marrow in Chronic Myelogenous Leukemia
  Acta Haematologica, 1983
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
  Nature, 1973